Skip to content
OpenSampling

2024 · Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · paywalled

Feasibility, reliability and satisfaction of (automated) capillary carcinoembryonic antigen measurements for future home-based blood sampling: the prospective CASA-I study

Voigt et al.

The finding, in our words

Capillary sampling for carcinoembryonic antigen showed near perfect agreement with venous results and was preferred by most participants, supporting reliable home based collection that could reduce hospital visits.

A paraphrase to the Library’s standard, never the abstract. The source is one link away and is always the authority.

Labels

  1. 2025

    This study established conversion methods for estimating plasma concentrations from whole blood VAMS samples for seven out of ten oral anticancer drugs, finding good agreement between capillary and venous samples. Patients reported a positive experience with home sampling using this microsampling technique.

    Clinical Application of Volumetric Absorptive Microsampling for Therapeutic Drug Monitoring of Oral Targeted Anticancer DrugsMeertens et al., Therapeutic drug monitoring · source ↗

    • vams
    • volumetric
    • venous-agreement
    • acceptability
    • blood
    • tdm
    • self-collection
    • dried
    • oncology
    • capillary
    • validation
  2. 2023

    VAMS matched serum for the kinase inhibitors nilotinib, cabozantinib, dabrafenib and ruxolitinib, r 0.94–0.97, with serum reliably predictable for the first three, and 93% of at-home samples were collected correctly: at-home VAMS shown feasible for routine cancer-drug monitoring.

    Clinical validation and feasibility of VAMS for monitoring of nilotinib, cabozantinib, dabrafenib, trametinib and ruxolitinibZimmermann et al., J. Pharmaceutical and Biomedical Analysis (paywalled) · source ↗

    • vams
    • venous-agreement
    • acceptability
    • blood
    • tdm
    • self-collection
    • haematocrit
    • dried
    • oncology
    • capillary
    • validation
  3. 2022

    Patients self-collected upper-arm capillary blood with press-activated devices including TAP II; autoantibody and CRP results agreed with venous at r≥0.98, were rated less painful, and 98.6% got enough blood within two attempts.

    Remote self-collection of upper-arm capillary blood for autoantibody analysis in immune-mediated rheumatic diseasesZarbl et al., RMD Open · source ↗

    • venous-agreement
    • acceptability
    • blood
    • self-collection
    • capillary
    • liquid
    • yourbio
    • biomarkers
  4. 2022

    The TAP device showed near perfect agreement with venous sampling for anti-Müllerian hormone measurements, with higher accuracy and lower pain compared to ADx card. This validates TAP as a reliable option for patient-led fertility hormone testing at home.

    Evaluation of at-home serum anti-Müllerian hormone testing: a head-to-head comparison studySilliman et al., Reproductive biology and endocrinology : RB&E · source ↗

    • venous-agreement
    • acceptability
    • blood
    • self-collection
    • capillary
    • fertility
    • hormones
    • yourbio
  5. 2026

    In AML and CLL, 91% of VAMS venetoclax results fell within 20% of plasma after individualised haematocrit correction; in home sampling, 18 of 21 patients self-sampled independently and 76% of returned samples were analysable, which shows home microsampling is workable, though the authors ask for multicentre validation.

    Clinical Validation of Venetoclax Volumetric Microsampling in Leukemia, with Whole-Blood-to-Plasma Conversion and Self-Microsampling FeasibilityLevens et al., Clinical Pharmacokinetics (paywalled) · source ↗

    • vams
    • venous-agreement
    • blood
    • dbs
    • tdm
    • self-collection
    • haematocrit
    • dried
    • oncology
    • capillary
    • validation